RE:Excellent NewsHaven't been following this for as long as some of you, but I haven't seen a NR flurry like this from Theralase before. IMO it's smart and adaptable that they are now trying to emphasize that their treatments can work in conjunction with the existing standards of care, instead of trying to be a standalone treatment. You know, because big pharma and all. We better watch out, the market cap might hit $50M after these 5 eyebrow raising NRs. lol (eye roll) Let's go!